Forebrain angiogenesis in Foxc1 mutant mice
Foxc1突变小鼠的前脑血管生成
基本信息
- 批准号:7952723
- 负责人:
- 金额:$ 7.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAddressAdultAffectAlcoholsAnatomyAreaAutomobile DrivingBackBehaviorBiochemicalBiomedical ResearchBlood VesselsBlood capillariesBrainCaliberCell CommunicationCell Culture TechniquesCell Differentiation processCell MaturationCell ProliferationCell SeparationCellsCerebral cortexCerebrumCessation of lifeChronic PhaseCore FacilityCuesDataDefectDesminDevelopmentDevelopment PlansDifferentiation AntigensDissectionDorsalEducationElementsEmbryoEndothelial CellsEnvironmentEnzymesEquipmentEtiologyEvaluationExperimental DesignsFacultyFetal Alcohol SyndromeFetal DevelopmentFishesFloorForebrain DevelopmentGene DosageGenerationsGenesGoalsHealthHybridsIncubatorsIndividualInstitutesInstitutionJournalsKnowledgeLigandsLightMedicalMeningealMeningesMentorsMentorshipMicroscopeMissionMitoticMolecularMutant Strains MiceNeocortexNeural CrestNeuronsNeurosciencesPathway interactionsPatient CarePerfusionPericytesPhasePhenotypePoint MutationPreparationProductionProsencephalonPublicationsPublishingResearchRoleSeveritiesSignal PathwaySignal TransductionSmooth Muscle MyocytesSpinal CordStrokeStructureSystemTechniquesTestingTimeTissuesTrainingTretinoinTubeUniversitiesVascularizationWorkangiogenesisanimal facilitybasecapillarycareercareer developmentcell growthcell typecollegedesigndisabilityfollow-upgraduate studenthindbrainimprovedinsightinterestmalformationmeetingsmembermutantneocorticalperineuralpleasurepost-doctoral trainingprogramspublic health relevancerelating to nervous systemresearch facilityresearch studyskillsstroke recoverytissue culturetranscription factorvasculogenesis
项目摘要
DESCRIPTION (provided by applicant): Dr. Julie Siegenthaler's initial interest in neuroscience started at Mount Holyoke College where she majored in the newly formed Neuroscience and Behavior program and was first introduced to experimental design and research while studying behavior in fish for her senior thesis project. After graduating cum laude with high honors in 2000, Dr. Siegenthaler pursued her interests in cellular and molecular neuroscience as a graduate student with Dr. Michael Miller at SUNY Upstate Medical University. While a graduate student, Dr. Siegenthaler described a role for TGF2 in neocortical development and as a potential target of alcohol in the brain defects seen in fetal alcohol syndrome. She continued in Dr. Miller's lab for a brief but productive postdoctoral training where she found that the transcription factor Foxg1 was an important regulator of TGF2 signaling in forebrain development. In total, Dr. Siegenthaler published five 1st author publications while at SUNY Upstate in such journals as Cerebral Cortex and Journal of Neuroscience. In May 2006, Dr. Siegenthaler joined Dr. Sam Pleasure's lab at UCSF where she began work on a project looking at the role of the secreted factors from the meninges in the development of the neocortex. Using Foxc1 mutant mice that fail to make complete meninges and have severe defects in forebrain development, she showed that meningeal-derived retinoic acid is key element driving neuron generation during corticogenesis. This research resulted in a first-author publication in the journal Cell. Dr. Siegenthaler has also generated substantial data regarded the brain vascular defects in the Foxc1 mutants and she is dedicated to developing an independent research plan focused on understanding how different structures and cell types contribute to the formation of the cerebral vasculature. Dr. Siegenthaler has developed a comprehensive career development plan to meet her career goals. While in the mentored K99 phase, Dr. Siegenthaler will continue to benefit from the mentorship and guidance of her sponsor, Dr. Sam Pleasure, and acquire new skills as she completes the specific aims outlined the Research Plan. The experimental data and techniques acquired during the K99 phase will be valuable in the research planned for the R00 phase. Dr. Siegenthaler's long-term goal is to develop a comprehensive, multi-faceted research program that investigates the development and function of the meninges in the embryo and adult, the functional role of Foxc1 in perivascular cells, and the interaction between the neural tissues and the vasculature during brain development. Environment. Dr. Siegenthaler has her own work space and desk on the 5th floor of Rock Hall on the Mission Bay Campus of UCSF. She has full access to the equipment and space of her mentor, Dr. Pleasure, including general lab equipment, centrifuges, freezers, a dissection room and adjacent tissue culture hood and incubators, microscopes, and space in the animal facility. She also has access to UCSF core facilities including those for cell sorting and real time PCR equipment. Dr. Siegenthaler has the equipment and facilities needed to complete the experiments outlined for the K99 phase. Her research will be conducted at UCSF, an extremely well-regarded research institution dedicated to improving the health of individuals through biomedical research, patient care and education. The research facilities at the Mission Bay Campus are part of a substantial effort by UCSF to improve and expand its research capabilities. Along with the neighboring Gladstone Institute, the Mission Bay Campus provides ample opportunities for Dr. Siegenthaler to attend seminars, presentations, journal clubs, and have informal meetings with faculty members that will contribute greatly to her training and preparation for an independent research career. Research. This proposal uses the Foxc1 mutant mice, which have defects in vascular and brain development, to gain further insight into how the brain vasculature forms. Experiments in the K99 phase are designed to understand how the absence of the meninges and defects in forebrain development in the Foxc1 mutants differentially contributes to the blood vessel malformations. Experiments in the R00 phase will investigate potential targets of meningeal-derived signals on endothelial cells, the cell autonomous role for Foxc1 in the differentiation and function of mural cells associated with the vasculature in and around the brain, and further explore the role of the neural-derived signals in the vascularization of the developing cortex. Foxc1 is expressed by neural crest-derived meningeal cells and mural cells (collective term for pericytes and smooth muscle cells) in the developing embryo and in the adult. Yet Foxc1 mutant mice have severe defects in both cortical development and formation of the forebrain vasculature. I have previously shown that the defects in dorsal forebrain development are due to loss of meningeal-derived retinoic acid. My preliminary evidence suggests that retinoic acid from the meninges also regulates endothelial cell proliferation and vessel formation around the forebrain (referred to as the perineural vascular plexus (PNVP). Experiments in specific aim 1 will specifically address the role of retinoic acid in the formation of the PNVP. In specific aim 2, I will address the role of Foxc1 in the differentiation and function of CNS mural cells using mural cell-specific ablation of Foxc1. In addition to defects in the PNVP, the intracortical vasculature fails to form properly in the Foxc1 mutants. In the third aim, I will test the hypothesis that the intracortical vascular phenotype in the Foxc1 mutants is due to loss of important angiogenic cues from the dorsal forebrain.
PUBLIC HEALTH RELEVANCE: Stroke is a significant cause of long-term disability and death and can result from congenital vascular defects that occur during fetal development. The research in this proposal seeks to significantly expand our understanding of what controls the formation of the vasculature in and around the cerebral cortex. Understanding how the cerebral vasculature forms will not only shed light on the etiology of congenital vascular malformations but also provide additional insight into the developmental angiogenic pathways that are likely reactivated during stroke recovery.
描述(由申请人提供):Julie Siegenthaler 博士最初对神经科学的兴趣始于 Mount Holyoke College,在那里她主修新成立的神经科学和行为项目,并在为她的高级论文项目研究鱼类行为时首次接触到实验设计和研究。 2000 年以优异成绩毕业后,Siegenthaler 博士在纽约州立大学上州医科大学跟随 Michael Miller 博士攻读研究生,继续追求自己对细胞和分子神经科学的兴趣。在还是一名研究生时,Siegenthaler 博士描述了 TGF2 在新皮质发育中的作用,以及作为酒精在胎儿酒精综合症中所见的大脑缺陷中的潜在目标。她继续在 Miller 博士的实验室进行短暂但富有成果的博士后培训,在那里她发现转录因子 Foxg1 是前脑发育中 TGF2 信号传导的重要调节因子。西根塔勒博士在纽约州立大学上州分校期间总共在《Cerebral Cortex》和《Journal of Neuroscience》等期刊上发表了五篇第一作者出版物。 2006 年 5 月,Siegenthaler 博士加入了 UCSF Sam Pleasure 博士的实验室,在那里她开始研究脑膜分泌因子在新皮质发育中的作用的项目。她利用无法形成完整脑膜且前脑发育严重缺陷的 Foxc1 突变小鼠表明,脑膜来源的视黄酸是皮质生成过程中驱动神经元生成的关键元素。这项研究以第一作者的身份发表在《细胞》杂志上。 Siegenthaler 博士还生成了有关 Foxc1 突变体脑血管缺陷的大量数据,她致力于制定一项独立的研究计划,重点了解不同的结构和细胞类型如何促进脑血管系统的形成。西根塔勒博士制定了全面的职业发展计划来实现她的职业目标。在 K99 指导阶段,西根塔勒博士将继续受益于她的资助者 Sam Pleasure 博士的指导和指导,并在完成研究计划概述的具体目标时获得新技能。 K99阶段获得的实验数据和技术对于R00阶段计划的研究非常有价值。 Siegenthaler 博士的长期目标是开发一个全面、多方面的研究计划,研究胚胎和成人脑膜的发育和功能、Foxc1 在血管周围细胞中的功能作用,以及神经组织和脑膜之间的相互作用。大脑发育过程中的脉管系统。 环境。西根塔勒博士在加州大学旧金山分校使命湾校区 Rock Hall 5 楼拥有自己的工作空间和办公桌。她可以完全使用她的导师 Pleasure 博士的设备和空间,包括一般实验室设备、离心机、冰柜、解剖室以及相邻的组织培养罩和培养箱、显微镜以及动物设施中的空间。她还可以使用 UCSF 的核心设施,包括细胞分选和实时 PCR 设备。 Siegenthaler 博士拥有完成 K99 阶段概述的实验所需的设备和设施。她的研究将在加州大学旧金山分校进行,这是一家备受推崇的研究机构,致力于通过生物医学研究、患者护理和教育来改善个人健康。使命湾校区的研究设施是加州大学旧金山分校为提高和扩展其研究能力而做出的重大努力的一部分。与邻近的格拉德斯通研究所一起,使命湾校区为西根塔勒博士提供了充足的机会参加研讨会、演讲、期刊俱乐部,并与教职员工举行非正式会议,这将极大地促进她的独立研究生涯的培训和准备。 研究。该提案利用 Foxc1 突变小鼠(其血管和大脑发育存在缺陷)来进一步了解大脑血管系统的形成方式。 K99 阶段的实验旨在了解 Foxc1 突变体中脑膜的缺失和前脑发育缺陷如何不同地导致血管畸形。 R00阶段的实验将研究内皮细胞上脑膜源性信号的潜在靶标、Foxc1在与大脑及其周围血管相关的壁细胞的分化和功能中的细胞自主作用,并进一步探索神经细胞的作用。 -发育中皮层血管化中的衍生信号。 Foxc1 在发育中的胚胎和成人中由神经嵴衍生的脑膜细胞和壁细胞(周细胞和平滑肌细胞的统称)表达。然而 Foxc1 突变小鼠在皮质发育和前脑脉管系统的形成方面都存在严重缺陷。我之前已经证明,背侧前脑发育缺陷是由于脑膜来源的视黄酸的损失造成的。我的初步证据表明,脑膜中的视黄酸还调节前脑周围的内皮细胞增殖和血管形成(称为神经周围血管丛(PNVP))。特定目标 1 中的实验将专门解决视黄酸在前脑形成中的作用。在具体目标 2 中,我将使用壁细胞特异性消融来探讨 Foxc1 在 CNS 壁细胞分化和功能中的作用。 Foxc1 除了 PNVP 的缺陷之外,Foxc1 突变体中的皮质内血管系统也无法正常形成。背侧前脑。
公众健康相关性:中风是长期残疾和死亡的一个重要原因,可能是由胎儿发育过程中发生的先天性血管缺陷引起的。该提案中的研究旨在显着扩大我们对控制大脑皮层内部和周围脉管系统形成的因素的理解。 了解脑血管系统的形成方式不仅可以阐明先天性血管畸形的病因,还可以进一步了解中风恢复期间可能重新激活的发育性血管生成途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julie Siegenthaler其他文献
Julie Siegenthaler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julie Siegenthaler', 18)}}的其他基金
Foxc1 control of meninges formation and function
Foxc1 控制脑膜形成和功能
- 批准号:
9769908 - 财政年份:2018
- 资助金额:
$ 7.7万 - 项目类别:
Retinoic Acid in Development of CNS Vasculature
视黄酸在中枢神经系统脉管系统发育中的作用
- 批准号:
9295069 - 财政年份:2016
- 资助金额:
$ 7.7万 - 项目类别:
Development and function the meninges arachnoid barrier
脑膜蛛网膜屏障的发育和功能
- 批准号:
10355920 - 财政年份:2016
- 资助金额:
$ 7.7万 - 项目类别:
Development and function of the meninges arachnoid barrier
脑膜蛛网膜屏障的发育和功能
- 批准号:
10620852 - 财政年份:2016
- 资助金额:
$ 7.7万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Functional, structural, and computational consequences of NMDA receptor ablation at medial prefrontal cortex synapses
内侧前额皮质突触 NMDA 受体消融的功能、结构和计算后果
- 批准号:
10677047 - 财政年份:2023
- 资助金额:
$ 7.7万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 7.7万 - 项目类别:
LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response
LRP1 作为成体神经干细胞和中风后反应中 CXCR4 的新型调节剂
- 批准号:
10701231 - 财政年份:2023
- 资助金额:
$ 7.7万 - 项目类别:
Mechanisms of Cardiac Injury Resolution by CX3CR1+ Macrophages
CX3CR1巨噬细胞解决心脏损伤的机制
- 批准号:
10719459 - 财政年份:2023
- 资助金额:
$ 7.7万 - 项目类别:
Investigating cerebrovascular dysfunction and cerebral atrophy in severe traumatic brain injury
严重颅脑损伤中脑血管功能障碍和脑萎缩的调查
- 批准号:
10742569 - 财政年份:2023
- 资助金额:
$ 7.7万 - 项目类别: